Evommune Ownership | Who Owns Evommune?

Overview Forecast RevenueFinancials Chart

Evommune Ownership Summary

Evommune is owned by 96.48% institutional investors, 3.15% insiders, and 0.37% retail investors. Eqt fund management s.a r.l. is the largest institutional shareholder, holding 15.64% of EVMN shares. Eventide Healthcare & Life Sciences I is the top mutual fund, with 3.33% of its assets in Evommune shares.

EVMN Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Evommune	96.48%	3.15%	0.37%
Sector	Healthcare Stocks	245.07%	12.10%	-157.17%
Industry	Biotech Stocks	380.48%	11.73%	-292.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Eqt fund management s.a r.l.	4.93M	15.64%	$113.33M
Ra capital management	3.49M	11.09%	$80.34M
Pivotal bioventure partners investment advisor	1.93M	6.11%	$44.30M
Andera partners	1.90M	6.02%	$43.62M
Rtw investments, lp	1.50M	4.77%	$34.54M
Jpmorgan chase	1.46M	4.63%	$32.11M
Nan fung group	1.44M	4.57%	$33.13M
Eventide asset management	1.21M	3.84%	$27.80M
Price t rowe associates inc /md/	1.12M	3.55%	$25.73M
Janus henderson group	896.70K	2.84%	$20.62M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Nan fung group	1.44M	27.32%	$33.13M
Andera partners	1.90M	24.66%	$43.62M
Pivotal bioventure partners investment advisor	1.93M	15.83%	$44.30M
Eqt fund management s.a r.l.	4.93M	11.10%	$113.33M
Velan capital investment management lp	446.25K	6.43%	$10.26M
Great point partners	325.00K	1.72%	$7.47M
Ra capital management	3.49M	0.85%	$80.34M
Blue owl capital lp	100.00K	0.62%	$2.30M
Eventide asset management	1.21M	0.46%	$27.80M
Rtw investments, lp	1.50M	0.34%	$34.54M

Top Buyers

Holder	Shares	% Assets	Change
Janus henderson group	896.70K	0.01%	896.70K
Baker bros. advisors lp	847.39K	0.11%	847.39K
Alyeska investment group	726.36K	0.05%	726.36K
Blackrock funding, inc. /de	673.57K	0.00%	531.13K
Freestone grove partners lp	337.29K	0.05%	337.29K

Top Sellers

Holder	Shares	% Assets	Change
Bioimpact capital	-	-	-1.46M
Marshall wace, llp	-	-	-879.73K
Kynam capital management, lp	-	-	-625.50K
Sectoral asset management	-	-	-589.00K
Abrdn	-	-	-525.38K

New Positions

Holder	Shares	% Assets	Change	Value
Janus henderson group	896.70K	0.01%	896.70K	$20.62M
Baker bros. advisors lp	847.39K	0.11%	847.39K	$19.48M
Alyeska investment group	726.36K	0.05%	726.36K	$16.70M
Freestone grove partners lp	337.29K	0.05%	337.29K	$7.75M
Blue owl capital lp	100.00K	0.62%	100.00K	$2.30M

Sold Out

Holder	Change
Royal bank of canada	-585.00
Plante moran financial advisors	-1.15K
Strs ohio	-1.80K
National bank of canada /fi/	-2.40K
China universal asset management	-5.00K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2026	116	38.10%	34,862,516	0.83%	96	0.91%	81	28.57%	13	18.18%
Mar 31, 2026	81	37.29%	34,361,905	26.33%	109	1.46%	61	3.39%	11	-
Dec 31, 2025	59	-	27,200,904	-	86	-	59	-	-	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Eventide Healthcare & Life Sciences I	1.21M	3.33%	-
Vanguard Total Stock Mkt Idx Inv	739.07K	2.05%	452.27K
Vanguard Morn Total Stk Mkt Idx Investor	739.07K	2.05%	452.27K
Vanguard MStar Total Stk Mkt Idx Invest	739.07K	2.04%	-
US Small-Cap Growth II Equity Comp	614.72K	1.71%	251.99K
American Century Small Cap Growth Inv	567.83K	1.58%	190.57K
American Century U.S. Small Cap Growth	567.83K	1.58%	190.57K
T. Rowe Price New Horizons	559.84K	1.54%	-22.88K
iShares Russell 2000 ETF	390.02K	1.07%	-4.48K
JPM Global Healthcare C acc USD	359.29K	1.00%	-9.85K

EVMN Ownership FAQ

Who Owns Evommune?

Evommune shareholders are primarily institutional investors at 96.48%, followed by 3.15% insiders and 0.37% retail investors. The average institutional ownership in Evommune's industry, Biotech Stocks , is 380.48%, which Evommune falls below.

Who owns the most shares of Evommune?

Evommune’s largest shareholders are Eqt fund management s.a r.l. (4.93M shares, 15.64%), Ra capital management (3.49M shares, 11.09%), and Pivotal bioventure partners investment advisor (1.93M shares, 6.11%). Together, they hold 32.84% of Evommune’s total shares outstanding.

Does Blackrock own Evommune?

BlackRock is not among the top 10 institutional shareholders of Evommune.

Who is Evommune’s biggest shareholder by percentage of total assets invested?

Nan fung group is Evommune’s biggest shareholder by percentage of total assets invested, with 27.32% of its assets in 1.44M Evommune shares, valued at 33.13M$.

Who is the top mutual fund holder of Evommune shares?

Eventide Healthcare & Life Sciences I is the top mutual fund holder of Evommune shares, with 3.33% of its total shares outstanding invested in 1.21M Evommune shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools